HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,602,201 | -0.2% | 196,497 | -5.1% | 0.04% | -2.7% |
Q2 2023 | $17,630,876 | +43.7% | 207,081 | +38.7% | 0.04% | +37.0% |
Q1 2023 | $12,267,241 | +164.5% | 149,291 | +152.2% | 0.03% | +145.5% |
Q4 2022 | $4,638,242 | +48.2% | 59,199 | +40.0% | 0.01% | +37.5% |
Q3 2022 | $3,130,000 | +550.7% | 42,283 | +468.8% | 0.01% | +700.0% |
Q2 2022 | $481,000 | -70.0% | 7,434 | -71.1% | 0.00% | -66.7% |
Q1 2022 | $1,606,000 | +331.7% | 25,713 | +266.9% | 0.00% | +200.0% |
Q4 2021 | $372,000 | -92.4% | 7,009 | -89.9% | 0.00% | -88.9% |
Q3 2021 | $4,887,000 | -18.8% | 69,225 | -24.0% | 0.01% | -10.0% |
Q2 2021 | $6,019,000 | +55.8% | 91,095 | +161.7% | 0.01% | +66.7% |
Q1 2021 | $3,864,000 | -43.3% | 34,808 | -39.5% | 0.01% | -50.0% |
Q4 2020 | $6,819,000 | -2.3% | 57,514 | -29.0% | 0.01% | 0.0% |
Q3 2020 | $6,978,000 | +36.4% | 81,041 | +38.8% | 0.01% | +50.0% |
Q2 2020 | $5,115,000 | +18.2% | 58,401 | +34.4% | 0.01% | +14.3% |
Q1 2020 | $4,329,000 | -75.2% | 43,437 | -71.4% | 0.01% | -65.0% |
Q4 2019 | $17,430,000 | -53.8% | 151,701 | -49.3% | 0.02% | -54.5% |
Q3 2019 | $37,729,000 | -52.9% | 299,101 | -55.5% | 0.04% | -50.6% |
Q2 2019 | $80,159,000 | -15.4% | 671,631 | -38.0% | 0.09% | -11.9% |
Q1 2019 | $94,785,000 | +9.1% | 1,083,510 | +24.8% | 0.10% | 0.0% |
Q4 2018 | $86,889,000 | +69.4% | 868,456 | +93.9% | 0.10% | +106.1% |
Q3 2018 | $51,307,000 | +222.1% | 447,783 | +152.1% | 0.05% | +206.2% |
Q2 2018 | $15,930,000 | +128.2% | 177,626 | +86.2% | 0.02% | +100.0% |
Q1 2018 | $6,981,000 | +957.7% | 95,413 | +740.2% | 0.01% | +700.0% |
Q4 2017 | $660,000 | +208.4% | 11,356 | +138.4% | 0.00% | – |
Q3 2017 | $214,000 | -35.7% | 4,764 | -41.9% | 0.00% | – |
Q1 2017 | $333,000 | +0.9% | 8,202 | 0.0% | 0.00% | – |
Q4 2016 | $330,000 | -80.1% | 8,202 | -82.1% | 0.00% | -100.0% |
Q3 2016 | $1,661,000 | +32.1% | 45,889 | +5.8% | 0.00% | +50.0% |
Q2 2016 | $1,257,000 | +363.8% | 43,359 | +416.4% | 0.00% | +100.0% |
Q3 2015 | $271,000 | -55.2% | 8,397 | -42.6% | 0.00% | 0.0% |
Q2 2015 | $605,000 | +136.3% | 14,619 | +135.8% | 0.00% | 0.0% |
Q2 2013 | $256,000 | +1.2% | 6,200 | 0.0% | 0.00% | 0.0% |
Q4 2012 | $253,000 | – | 6,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |